Navigation Links
Viralytics Full Year Financial Results
Date:9/3/2013

ustralia and the UK)

  • Broad anti-cancer activity of CAVATAK™ demonstrated in preclinical setting.
  • Synergistic effect from the combination of CAVATAK™ and Docetaxel.  Potential combination therapy.
  • Combination with either radiation or chemotherapy resulted in more potent anticancer activity in bladder cancer cell lines than radiation or chemotherapy alone.
  • Potent anti-cancer activity in chronic lymphocytic leukaemia (CLL) cell lines.
  • "The 2013 financial year has been one of outstanding progress at Viralytics, which leaves us well positioned to further develop the business in the coming year," said Dr. Malcolm McColl, Chief Executive Officer of Viralytics. "We have achieved key milestones in our Phase 2 CALM study, with interim results demonstrating promising anti-cancer activity. We also had a number of excellent outcomes in our Phase 1 and preclinical programs, demonstrating the broad anti-cancer activity of CAVATAK™.  Our focus is to maintain momentum in clinical development and translate this progress into valuable commercial outcomes."

    About Viralytics Ltd:
    Viralytics is developing oncolytic virotherapy treatments for a range of cancers.  Viralytics' lead product, CAVATAK™, is a proprietary formulation of the common cold Coxsackievirus Type A21 (CVA21).  CVA21 binds to specific "receptor" proteins highly expressed on multiple cancer types including, but not limited to melanoma, prostate, lung, breast and bladder cancers; and multiple myeloma.  Intratumourally administered CAVATAK™ is currently being studied in a Phase 2 clinical trial in the treatment of Late stage Melanoma (the CALM study) at multiple cancer clinics in the US.  Viralytics also plans to commence a Phase 1/2 study of CAVATAK™ delivered intravenously in patients with melanoma, prostate, lung or metastatic bladder cancers prior to the en
    '/>"/>

    SOURCE Viralytics Ltd.
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3

    Related medicine technology :

    1. China Nepstar Chain Drugstore Ltd. Reports Second Quarter 2013 Financial Results
    2. International Isotopes Inc. Announces Second Quarter and Six Months 2013 Financial Results
    3. ULURU Inc. Reports Second Quarter 2013 Financial Results
    4. Tengion Provides Business Update and Reports Second Quarter 2013 Financial Results
    5. EntreMed Reports Second Quarter 2013 Financial Results
    6. Savient Pharmaceuticals Reports Second Quarter 2013 Financial Results
    7. Sinovac Reports Unaudited Second Quarter 2013 Financial Results
    8. Vasomedical Announces Financial Results for the Second Quarter of 2013
    9. Nephros Reports Second Quarter 2013 Financial Results
    10. Regulus Reports Second Quarter 2013 Financial Results and Recent Highlights
    11. Dynasil Corporation of America Reports Third Quarter Fiscal 2013 Financial Results
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:3/31/2015)... , March 31, 2015 ... "Life Science and Chemical Instrumentation Market (Chromatography, Electrophoresis, DNA ... Flow Cytometer, Incubator, Fume Hood, Centrifuge) - Global ... Life Science and Chemical Instrumentation Market is expected ... of 6.9% from 2014 to 2019. ...
    (Date:3/31/2015)... , March 31, 2015  Mark Farrah Associates ... Medicare Advantage (MA) plans in their recent analysis ... people were enrolled in Medicare Advantage plans as ... 1.3 million members year-over-year.  54.3 million people are ... Medicare and Medicaid Services (CMS), with an unpenetrated ...
    (Date:3/31/2015)... , March 31, 2015  On May ... will convene in Santa Monica, CA ... on Lung-Sparing Therapies for Malignant Pleural Mesothelioma (MPM), ... exposure to asbestos and commonly affects the lining ... co-hosted by UCLA and the Pacific Mesothelioma Center ...
    Breaking Medicine Technology:Life Science and Chemical Instrumentation Market Worth $48.84 Billion by 2019 2Life Science and Chemical Instrumentation Market Worth $48.84 Billion by 2019 3Life Science and Chemical Instrumentation Market Worth $48.84 Billion by 2019 4Life Science and Chemical Instrumentation Market Worth $48.84 Billion by 2019 5Medicare Advantage Enrollment Reaches 17 Million According to Mark Farrah Associates 2Cutting-Edge Research to Be Presented at 5th Annual International Symposium on Lung-Sparing Therapies for Malignant Pleural Mesothelioma in Santa Monica 2Cutting-Edge Research to Be Presented at 5th Annual International Symposium on Lung-Sparing Therapies for Malignant Pleural Mesothelioma in Santa Monica 3Cutting-Edge Research to Be Presented at 5th Annual International Symposium on Lung-Sparing Therapies for Malignant Pleural Mesothelioma in Santa Monica 4
    (Date:3/31/2015)... 31, 2015 Students, teachers, and the ... education in a drastically different way as current and ... and training content is being delivered and received. , ... technology in an unprecedented way with education becoming individualized, ... co-founder and CEO, My Mobile University , This ...
    (Date:3/31/2015)... Dr. St. Ledger recently returned from yet another trip ... Here, he participated in the Worn Dentition Workshop: a ... in cases of severely worn teeth, as well as the ... correlation to GERD and Sleep Apnea. , Dr. ... After the workshop he attended, he mentored for three days ...
    (Date:3/31/2015)... 2015 Researchers at UC Davis ... humans: how human livers heal. The difference centers ... regeneration. Normally, mouse PPARa is far more active ... to quickly regenerate damaged livers. However, the research ... can boost the regenerative effects of human PPARa. ...
    (Date:3/31/2015)... Princeton, NJ (PRWEB) March 31, 2015 ... a white paper entitled, “The Value of an ... report continues to play a critical role in ... health systems. With the appropriate understanding and review, ... decision support and strategic planning. , This white ...
    (Date:3/31/2015)... With intravenous (IV) infusion therapy, medication ... Patients, typically, are prescribed IV infusion therapy when their ... no longer effective. Illness often leads to dehydration, ... electrolyte imbalances. Infusion therapy benefits the patient’s recovery ... treating dehydration, IV infusion therapy can be used to ...
    Breaking Medicine News(10 mins):Health News:LTT Global Communications Launches First Asia Holistic Online Learning Platform 2Health News:LTT Global Communications Launches First Asia Holistic Online Learning Platform 3Health News:The dentists at Upper Montclair Dental Associates are happy to announce exciting new happenings at their practice. 2Health News:UC Davis Study Finds Protein May Improve Liver Regeneration 2Health News:UC Davis Study Finds Protein May Improve Liver Regeneration 3Health News:UC Davis Study Finds Protein May Improve Liver Regeneration 4Health News:Intravenous Infusion Therapy Now Available at Urgent Care of Texas Centers; Hospital-Level Care in an Outpatient Setting. 2
    ... University from the National Institutes of Health,s Fogarty International ... in Health Informatics. The new center will ... informatics programs at IU and the Regenstrief Institute with ... Africa at Moi University and Moi Teaching and Referral ...
    ... drug by adolescents, with almost 42% of high school ... use may result in a number of serious consequences ... of cancer. As such, it is critical to prevent ... scientists have been trying to establish the best means ...
    ... , ... Medicare, and Medicaid Plans Recognized Among The Nation,s Top 25, , ... Albany, N.Y. (Vocus) November 16, 2009 -- Underscoring ... was ranked as the top-rated health plan in New York state, according to the ...
    ... , Accepts Report of Blue Ribbon Advisory Panel ... 21st century care, Secretary of Veterans Affairs Eric K. Shinseki ... Veterans Affairs (VA) and the schools that train the nation,s ... of higher education for health care professionals have been essential ...
    ... African Services Committee Applauds City for Its Efforts to ... YORK, Nov. 16 African Services Committee is praising New ... putting the second-generation female condom into the hands of women ... enthusiastically endorse New York City,s efforts to scale up access ...
    ... , , FRANKLIN, Tenn., Nov. 16 ... point of agreement by all parties is that some form ... that now is the worst time for government-mandated change because ... industry. One Franklin Tennessee-based software company is defining that innovation ...
    Cached Medicine News:Health News:Indiana University receives NIH grant to improve health care in East Africa 2Health News:Indiana University receives NIH grant to improve health care in East Africa 3Health News:The straight dope: Studies link parental monitoring with decreased teen marijuana usage 2Health News:CDPHP Rated Top Plan In New York State By U.S. News & World Report/NCQA America's Best Health Insurance Plans 2009-10* 2Health News:CDPHP Rated Top Plan In New York State By U.S. News & World Report/NCQA America's Best Health Insurance Plans 2009-10* 3Health News:Secretary Enhancing Partnerships with Medical Schools 2Health News:NYC's African Diaspora Community Welcomes the Second-Generation Female Condom (FC2) 2Health News:NYC's African Diaspora Community Welcomes the Second-Generation Female Condom (FC2) 3Health News:Health Care Robots: Next Generation Decision-Making Software, Eliminates Manual Systems Labor 2Health News:Health Care Robots: Next Generation Decision-Making Software, Eliminates Manual Systems Labor 3
    Portless Sheath Introducers...
    Introducer Sheath Designed for Vascular Access...
    Used to introduce balloon, electrode, closed or non-tapered end and,other catheters....
    ... Driver Stent design, utilizing an ... limitations of stainless steel stents. ... thinner struts, for unparalleled flexibility ... Driver Coronary Stent Systemwith thin ...
    Medicine Products: